Global law firm White & Case LLP has advised Neopharmed Gentili on its debut issuance of €750 million senior secured fixed and floating high yield notes as well as entry into a new €130 million revolving credit facility.
The offering represents the largest European refinancing in 2024 to date of private credit debt solely with syndicated high yield bonds.
Neopharmed Gentili, a portfolio company of Ardian and NB Renaissance, is a leading Italian primary care pharmaceutical company.
The White & Case team that advised on the transaction’s capital markets aspects was led by partners Michael Immordino (London & Milan) and Evgeny Scirto Ostrovskiy (Milan & London) and included associates Alessio D’Alessandro (Milan) and lawyers Noemi Stimamiglio and Roberta Monasterolo (both Milan). The team that advised on the debt finance aspects included partners Iacopo Canino and Stefano Bellani (both Milan) and associate Beatrice Bertuzzi (Milan). The team that advised on US tax aspects included partner Chad McCormick (Houston) and associate Daniel Park (New York).
Press contact
For more information please speak to your local media contact.
Read the orginal article: https://www.whitecase.com/news/press-release/white-case-advises-neopharmed-gentili-debut-eu750-million-high-yield-senior
